One penny stock profiled here as a good penny stock to watch was Generex Biotechnology Corp. (OTCBB: GNBT.OB) who filed their 10-Q yesterday for the quarter ended January 31, 2012. As most biotech companies researching cures to certain cancers, GNBT has been struggling to meet its cash requirements for years but may be on the cusp of announcing a major breakthrough in the fight against breast cancer.
On January ...
Continue Reading →
Penny Stock Generex Biotechnology Corp. (OTCBB: GNBT.OB) traded more than 3x its Average Volume today reaching as high as 0.19 at one point in the day’s trading session.
GNBT closing price today was $0.155, down -10.40% (-0.018).
GNBT traded volume of 6,024,288.
GNBT is trading:
When the year started, we alerted about a good Penny Stock to buy, Generex Biotechnology Corp. (OTCBB: GNBT.OB). Well, Generex Biotech, whose search for the cure to breast cancer continues in after successful Phase II clinicals, announced today that it has been awarded a Japanese Patent for its wholly ...
Generex Biotechnology Corporation (OTCBB: GNBT) announced today that it has secured two commitments for an aggregate capital raise of CA$3,600,000. This funding is structured as term loans of one year from private lenders secured by the Company’s real estate. Interest on the loans is payable monthly at the rate of 10% per annum.
“This capital infusion will permit ...
Continue Reading →